Oblenio Bio Raises $62M to Advance New Therapies for Autoimmune Diseases

Thursday, June 25, 2026Win WarfieldView original

Cambridge, Mass.-based Oblenio Bio has raised an oversubscribed $62 million Series B funding round led by Pfizer Ventures, as the... Read More